Valsartan

Drug ingredient

CAS 137862-53-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 137862-53-4
US productionNot reported
Import value, 2024$1.4B
Top sourceIreland 33%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 293399 · basket

These shares come from HS customs code 293399, which covers 518 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
IE 33%IrelandCN 26%ChinaIN 11%IndiaDE 9%GermanyIT 4%Italy
67 FDA-registered drug labelers
A-S Medication Solutions
Advagen Pharma Ltd
Alembic Pharmaceuticals Inc.
Alembic Pharmaceuticals Limited
American Health Packaging
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals NY LLC
Amneal Pharmaceuticals of New York LLC
ANI Pharmaceuticals, Inc.
Aphena Pharma Solutions - Tennessee, LLC
Archis Pharma LLC
Ascend Laboratories, LLC
Aurobindo Pharma Limited
AvKARE
AvPAK
Biocon Limited
Biocon Pharma Inc.
Bryant Ranch Prepack
Cadila Pharmaceuticals Limited
Camber Pharmaceuticals, Inc.
Chromo Laboratories India Private Limited
Coupler LLC
Direct_Rx
Divi's Laboratories Limited
Dr. Reddy's Laboratories Inc.
Dr. Reddy's Laboratories Limited
Golden State Medical Supply, Inc.
Harman Finochem Limited
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Hetero Labs Limited
IOL Chemicals and Pharmaceuticals Ltd.
Ipca Laboratories Limited
Jubilant Biosys limited
Jubilant Cadista Pharmacuticals Inc.
Laurus Labs Limited
Lifsa Drugs LLC
Lupin Pharmaceuticals, Inc.
Macleods Pharmaceuticals Limited
Major Pharmaceuticals
Matrix Pharmacorp Private Limited
MSN Life Sciences Private Limited
Mylan Pharmaceuticals Inc.
Northwind Health Company, LLC
Novadoz Pharmaceuticals LLC
Novartis Pharmaceuticals Corporation
Novugen Pharma (USA) LLC
Ohm Laboratories Inc.
PD-Rx Pharmaceuticals, Inc.
Preferred Pharmaceuticals Inc.
Proficient Rx LP
ScieGen Pharmaceuticals, INC.
Second Pharma Co.,ltd.
Siegfried Barbera, SL
Sionc Pharamaceuticals Pvt Ltd
Solco Healthcare US, LLC
Somerset Therapeutics, LLC
SQUARE PHARMACEUTICALS LIMITED
Sterling Pharma Solutions Limited
Strides Pharma Science Limited
Torrent Pharmaceuticals Limited
Unichem Pharmaceuticals (USA), Inc.
Viona Pharmaceuticals Inc
XLCare Pharmaceuticals Inc
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
Zhuhai Rundu Pharmaceutical Co., Ltd.
Zydus Lifesciences Limited
Zydus Pharmaceuticals USA Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 12 drug and cosmetic product listings (FDA).

  • •valsartan and hydrochlorothiazide
  • •Valsartan
  • •Diovan
  • •sacubitril and valsartan
  • •Amlodipine, Valsartan, Hydrochlorothiazide
  • •Amlodipine and Valsartan
  • •Entresto
  • •Exforge HCT
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Valsartan Tablet

    Shortage listed since November 19, 2025

See all current drug shortages

Chemical Identity

CAS137862-53-4
PubChem CID60846
DTXSIDDTXSID6023735
FormulaC24H29N5O3
Mol. Weight435.5 g/mol
SMILESCCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O

Data Sources

Brief citations

Valsartan (CAS 137862-53-4) https://chemicalindependence.com/chemical/137862-53-4/ PubChem: 60846. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/60846 FDA National Drug Code directory: CAS 137862-53-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 137862-53-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 293399 for CAS 137862-53-4. Reporting year: 2024. https://usatrade.census.gov/